Beijing, China

Fengyu Guo

This inventor holds 1 USPTO granted patent. Top assignee: China Agricultural University. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fengyu Guo. Retrieved from https://idiyas.com/inventor/fengyu-guo-drdvn70p

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Fengyu Guo in Chemical Drug Development.

Introduction

Fengyu Guo is a notable inventor based in Beijing, China. He has made significant contributions to the field of chemical drugs, particularly in the development of compounds with α-glucosidase inhibitory activity. His work is essential in the fight against diabetes, showcasing the potential of innovative drug compounds.

Latest Patents

Fengyu Guo holds two patents, one of which is titled "Compound with α-glucosidase inhibitory activity and application thereof." This invention pertains to a compound that exhibits strong anti-diabetes activity, specifically a series of compounds represented by the general formula (I). The compound, 5-hydroxymethyl-8-methyl-2-(N-arylamino)-pyrano[2,3-c]pyridine-3-(N-aryl)-formamide, demonstrates significant application value compared to other anti-diabetes compounds.

Career Highlights

Fengyu Guo is affiliated with China Agricultural University, where he conducts research and development in the field of chemical drugs. His work has garnered attention for its innovative approach to addressing diabetes through the development of new compounds.

Collaborations

Fengyu Guo collaborates with notable colleagues, including Ran Wang and Pengjie Wang, who contribute to his research efforts and advancements in the field.

Conclusion

Fengyu Guo's contributions to the development of anti-diabetes compounds highlight his innovative spirit and dedication to improving health outcomes. His work continues to pave the way for advancements in chemical drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…